Montreal Heart Institute Becomes the First in Canada to Deploy Shimadzu's Trinias Opera Through Strategic Partnership with Christie Innomed
FrançaisNew state-of-the-art hemodynamics suite brings innovative cardiovascular imaging technology to Canadian patients and clinicians
ST-EUSTACHE, QC, Nov. 9, 2026 /CNW/ -- The Montreal Heart Institute (MHI), in partnership with Christie Innomed and Shimadzu Corporation, announced the opening of its new Hemodynamics Room #3 featuring the Trinias with SCORE Opera (Trinias Opera), marking the first installation of this advanced modality in Canada. The milestone reflects a shared commitment to advancing cardiovascular care through innovation, clinical excellence, and world-class collaboration.
The Trinias Opera is an advanced cardiovascular imaging platform used during minimally invasive procedures to help physicians visualize the heart and blood vessels in real time. By combining high-quality imaging with intelligent processing tools, the system supports clinicians during complex procedures by improving device visibility while helping to create a more efficient experience in the procedure room. The technology is designed to support clinical decision-making and contributes to the ongoing evolution of patient-centred cardiovascular care.
As one of the world's leading cardiovascular centres, the MHI continues to strengthen its position as a reference centre for interventional cardiology through investments in cutting-edge technology and patient-centred innovation. The introduction of the Trinias Opera underscores MHI's mission to continuously improve patient outcomes while empowering clinicians with advanced tools to enhance diagnostic and interventional precision.
A Strategic Partnership Driving Innovation
The deployment of the Trinias Opera is the result of a close collaboration between the MHI, the Montreal Heart Institute Foundation, Christie Innomed, Shimadzu Corporation, Shimadzu Medical Systems USA, and Shimadzu Software Development Corporation. Together, the organizations have combined clinical expertise, technological leadership and implementation excellence to deliver a solution tailored to the Institute's evolving needs and the growing demand for cardiovascular care.
"This project demonstrates what is possible when healthcare providers and technology leaders come together with a common purpose: driving innovation that can make a real difference in cardiovascular care. We are proud to partner with the Montreal Heart Institute and Shimadzu to introduce Canada's first Trinias Opera system and help bring the next generation of cardiovascular imaging to clinicians and patients."
-- Nicolas Vachon, President and Chief Executive Officer, Christie Innomed
"Innovation is most meaningful when it enables clinicians to make better decisions and deliver better outcomes. We are honoured that the Montreal Heart Institute has chosen Shimadzu's Trinias Opera platform and proud to collaborate with Christie Innomed on this landmark Canadian installation."
-- Kiyohito Sonoki, General Manager, Medical Systems Division, Shimadzu Corporation
"The Montreal Heart Institute has always embraced innovation in support of our mission to improve cardiovascular health. This new hemodynamics suite strengthens our ability to provide the highest level of care to patients while ensuring our clinical teams have access to the most advanced tools available."
-- Nesrine Ragguem, President and Chief Executive Officer, Montreal Heart Institute
"Behind every innovation that transforms care is a community of partners and donors who believe in the power of progress. We are deeply grateful to Christie Innomed and Shimadzu for this significant equipment donation, which will enable the Montreal Heart Institute to remain at the forefront of cardiovascular innovation and provide patients with access to the most advanced technologies available."
-- Karl Blackburn, President and CEO of the MHI Foundation
Transforming Care for Patients and Clinicians
The Trinias Opera introduces the latest generation of image post-processing technology, including deep-learning artificial intelligence capabilities designed to enhance image quality and support real-time clinical decision-making. The platform supports cardiovascular interventions by enhancing the visualization of devices while improving workflow and collaboration within the procedure room.
Its deep-learning-based AI filter extracts linear structures to reduce image noise and enhance contours, helping maintain device visibility even at low X-ray doses. Because the level of visibility required can vary depending on the patient's size and characteristics, the treatment being performed, and the operator's vision, the system allows the X-ray dose to be controlled flexibly, supporting dose reduction during procedures.
A Canadian First Focused on the Future
As the first Trinias Opera installation in Canada, this project represents more than the introduction of a new imaging platform. It signals a commitment to advancing the future of cardiovascular medicine by bringing advanced and new AI image processing technology into environments where it can have the greatest impact on patient outcomes. The installation opens new possibilities for diagnostic and interventional precision while further establishing the Montreal Heart Institute as a leader in clinical innovation.
By combining world-class clinical expertise with innovative imaging technology, the Montreal Heart Institute, Christie Innomed and Shimadzu are setting a new benchmark for cardiovascular care in North America. Through continued collaboration between Shimadzu's researchers and MHI's clinical experts, this partnership will help drive future innovations designed to enhance patient care, support clinicians, and redefine what is possible in the interventional environment.
About the Montreal Heart Institute Foundation
Founded in 1977, the Foundation raises and administers funds to support the MHI's innovative projects and fight cardiovascular diseases, the world's number one cause of mortality. Thanks to the Foundation's philanthropic events and contributions from donors, the MHI has become a global pioneer in cardiovascular health and the nation's leading cardiology research centre. Since it was founded, the Foundation has raised more than $400 million. These funds have made major breakthroughs possible and are used to support the MHI's specialists, professionals, and researchers as they provide cutting-edge care to tens of thousands of Quebecers.
About the Montreal Heart Institute
Founded in 1954, the Montreal Heart Institute (MHI) continuously strives for the highest standards of excellence in the cardiovascular field through its leadership in clinical and fundamental research, ultraspecialized care, professional training, and prevention. It is home to the largest cardiovascular research center, the largest cardiovascular prevention center, and the largest cardiovascular genetics center in Canada. MHI is affiliated with the Université de Montréal and has more than 2,400 employees, including 230 physicians and over 130 researchers. www.icm-mhi.org
About Christie Innomed
Founded in 1954, Christie Innomed develops, distributes, integrates, and supports innovative medical imaging and medical information management equipment that improves the performance of healthcare institutions. Christie Innomed is a leader in Medical Imaging Equipment Solutions, Service Solutions & Multi-Vendor Services (MVS), and Health IT Solutions, with over 200 dedicated specialists serving more than 2,500 hospitals and clinics across Canada and the United States. Through its commitment to innovation and service, Christie Innomed contributes every day to making healthcare more accessible, more efficient, and more human. To learn more about Christie Innomed, visit www.christieinnomed.com or connect with us on LinkedIn.
About Shimadzu Corporation
Founded in Kyoto, Japan, Shimadzu Corporation is a global leader in precision instruments, medical systems, and industrial technologies. Guided by its commitment to advancing science and technology for society, Shimadzu develops innovative healthcare solutions that support clinicians and improve patient outcomes worldwide.
SOURCE Christie Innomed
For media inquiries: Muriel Haraoui, Christie Innomed, (514) 265-5631, mharaoui@christieinnomed.com
Share this article